SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-19-001248
Filing Date
2019-02-21
Accepted
2019-02-21 16:10:35
Documents
1
Period of Report
2019-02-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5454
  Complete submission text file 0000902664-19-001248.txt   7402
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
venBio Select Advisor LLC (Reporting) CIK: 0001633313 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 19621973

Mailing Address C/O VENBIO SELECT ADVISOR LLC 120 W. 45TH STREET, 28TH FLOOR NEW YORK NY 10036
Business Address
Aghazadeh Behzad (Reporting) CIK: 0001701815 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 19621974